Subscribe to Entrepreneur for $5

Cross That Bridge

Juggling growth and financial risk is one balancing act you can't afford not to master.

This story appears in the February 2004 issue of Entrepreneur. Subscribe »

When Regenesis Biomedical Inc., kicked off an aggressive sales campaign to cultivate a new customer segment, it marked a major-and risky-shift in the equipment company's longtime marketing strategy.

In 2001, Regenesis launched and started promoting its Provant Wound Closure System, which stimulates cells to replicate and express genes faster, to the home-care industry. But strict Medicare and Medicaid reimbursement rules severely limited its marketing base to certain private insurance clients.

Continue Reading This Article—And Everything on Entrepreneur!

Become a member to get unlimited access to for less than $1 per week* and support the voices you want to hear more from.*Billed annually at $49/year. Cancel anytime.